Browse Items (5 total)
- Tags: Monoclonal
Concurrent treatment of chronic psoriasis and asthma with ustekinumab.
Tags: 2014, Amarnani Ajay, Antibodies, Asthma/*drug therapy, Brodell Robert T, Chronic Disease, Female, Humanized/metabolism/*therapeutic use, Humans, Immunosuppressive Agents/metabolism/*therapeutic use, Inflammation/drug therapy, Injections, Interleukin-12/metabolism, Interleukin-23/metabolism, Mercado Jorge M, Middle Aged, Monoclonal, Monoclonal/administration & dosage/immunology/therapeutic use, Psoriasis/*drug therapy, Rosenthal Ken S, Subcutaneous, The Journal of dermatological treatment, Ustekinumab
Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis.
Tags: 2010, Anti-Inflammatory Agents/adverse effects/*therapeutic use, Antibodies, Etanercept, Evidence-Based Medicine, Expert opinion on biological therapy, Feldman Steven R, Humanized, Humans, Immunoglobulin G/adverse effects/*therapeutic use, Immunosuppressive Agents/adverse effects/*therapeutic use, Monoclonal, Monoclonal/adverse effects/*therapeutic use, Patient Selection, Psoriasis/*drug therapy/immunology, Receptors, Risk Assessment, Severity of Illness Index, Treatment Outcome, Tumor Necrosis Factor/*therapeutic use, Uhlenhake Elizabeth E, Ustekinumab
The use of eculizumab in gemcitabine induced thrombotic microangiopathy.
Tags: *Gemcitabine, *Hemolytic uremic syndrome, *Pancreatic cancer, *Renal failure, *Thrombotic microangiopathy, 2018, Antibodies, Antimetabolites, Antineoplastic – Adverse Effects, Antineoplastic/*adverse effects, BMC nephrology, Das Abhijit, Deoxycytidine, Deoxycytidine – Adverse Effects, Deoxycytidine/adverse effects/*analogs & derivatives, Department of Internal Medicine, Female, Gupta Mohit, Humanized/*therapeutic use, Humans, Krishnappa Vinod, Middle Age, Middle Aged, Monoclonal, Monoclonal – Therapeutic Use, NEOMED College of Graduate Studies Student, NEOMED College of Medicine, Novak Robert, Raina Rupesh, Scales, Shah Haikoo, Tanphaichitr Natthavat, Thrombocytopenia – Chemically Induced, Thrombocytopenia – Diagnosis, Thrombocytopenia – Drug Therapy, Thrombotic Microangiopathies/*chemically induced/diagnosis/*drug therapy
Herpes simplex virus type 1 that exhibits herpes simplex virus type 2 sensitivity to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Tags: 1991, Animals, Antibodies, Antiviral Agents/*pharmacology, Bromodeoxyuridine/*analogs & derivatives/pharmacology, DNA, Dobson A T, Docherty J J, Drug Resistance, Female, Fluorescent Antibody Technique, Humans, Intervirology, Jennings B A, Microbial, Monoclonal, Simplexvirus/*drug effects/enzymology/genetics, Thymidine Kinase/analysis/genetics, Trimble J J, Viral/analysis/biosynthesis, Virus Replication/drug effects
Postmortem vitreous bevacizumab levels of an infant treated for retinopathy of prematurity.
Tags: *Retinopathy of Prematurity, 2016, Angiogenesis Inhibitors, Antibodies, Bevacizumab/*analysis, Bouhenni Rachida, Department of Pharmaceutical Sciences, Gestational Age, Hanna Nancy, Hertle Richard W, Humanized, Humans, Hypes Stephen, Infant, Intravitreal Injections, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, Lawhon William, Monoclonal, Nasser Orwa, NEOMED College of Pharmacy, Newborn, Vascular Endothelial Growth Factor A, Vitreous Body/*chemistry